Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.58 USD | +2.43% | -2.72% | +69.67% |
Mar. 19 | Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants | MT |
Mar. 15 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 54.24M | Sales 2025 * | 230M | Capitalization | 2.11B |
---|---|---|---|---|---|
Net income 2024 * | -214M | Net income 2025 * | -110M | EV / Sales 2024 * | 36.3 x |
Net cash position 2024 * | 142M | Net cash position 2025 * | 121M | EV / Sales 2025 * | 8.63 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-21.1
x | Employees | 141 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.91% |
Latest transcript on Geron Corporation
1 day | +2.43% | ||
1 week | -2.72% | ||
Current month | +8.48% | ||
1 month | +8.16% | ||
3 months | +72.12% | ||
6 months | +95.63% | ||
Current year | +69.67% |
Managers | Title | Age | Since |
---|---|---|---|
John Scarlett
CEO | Chief Executive Officer | 73 | 11-09-28 |
Director of Finance/CFO | 57 | 23-09-24 | |
Faye Feller
CTO | Chief Tech/Sci/R&D Officer | 42 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
V. Lawlis
BRD | Director/Board Member | 72 | 12-03-14 |
John Scarlett
CEO | Chief Executive Officer | 73 | 11-09-28 |
Susan Molineaux
BRD | Director/Board Member | 70 | 12-09-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% | ||
0.07% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 3.58 | +2.29% | 6,966,977 |
24-04-23 | 3.5 | -6.17% | 10,388,428 |
24-04-22 | 3.73 | +1.08% | 8,217,024 |
24-04-19 | 3.69 | -1.07% | 8,226,233 |
24-04-18 | 3.73 | +1.36% | 9,740,360 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.67% | 2.11B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.80% | 22.2B | |
-16.53% | 21.23B | |
-9.10% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- GERN Stock